YA-101

Advertisement

cGxPJobs Banner

Dasher Neuroscience Advances YA-101 Phase 2 Trial

TAIPEI, July 28, 2026 Dasher Neuroscience Holdings Inc. has successfully completed patient enrollment in its global Phase 2 clinical...

By cGxPwire Editor
July 29, 2026

Read More

Advertisement

cGxPJobs

Directory